Heartburn drugs containing omeprazole marketed in the European Union are set to carry a new warning about potential kidney inflammation.
Kidney Inflammation Warning For PPI Omeprazole In Europe
Cases of acute tubulointerstitial nephritis linked to omeprazole use flagged to the EMA leads to new product information warnings related to a possible risk of kidney inflammation for drugs containing the PPI sold in the EU.
